alpha 1-adrenergic-receptor inhibitors , such as prazosin and doxazosin , represent an attractive choice for initial therapy in all grades of hypertension and are especially appropriate in hypertensive patients with congestive heart failure , asthma and chronic obstructive airways disease , renal impairment , diabetes mellitus , hyperlipidemia , benign prostatic hyperplasia , or gout , and in those involved in vigorous work , sports , or exercise .
C0032912
prazosin
C0114873
doxazosin